Can a South Carolina resident get peptides by telehealth?
Section 40-47-37 of the South Carolina Code (rewritten by 2024 Act No. 120, effective March 11, 2024) governs telemedicine by physicians. A licensee must hold a South Carolina license, meet the in-person standard of care, and prescribe in accordance with section 40-47-113. A licensee who practices solely by telemedicine must also verify the patient's identity and location and provide an appropriate evaluation, which need not be in person if the licensee can accurately diagnose and treat through telehealth. At each encounter the threshold information needed for an accurate diagnosis must be obtained in a medical history interview conducted by the prescribing licensee, and a relationship may not be established by telemedicine for prescribing when an in-person physical examination is necessary. Section 40-47-113(C) makes it unprofessional to prescribe to someone the licensee has never personally examined based solely on answers to a set of questions. Schedule II and III narcotics are barred by telemedicine outside narrow exceptions; the peptides in this database are not scheduled. This record leaves asynchronous prescribing unresolved because the statute is ambiguous: it requires an interview conducted by the prescriber and bars questionnaire-only prescribing, but it never says whether that interview must take place in real time. [3] [4]
How does the South Carolina pharmacy board treat compounding?
| Board | South Carolina Board of Pharmacy (South Carolina Department of Labor, Licensing and Regulation) |
|---|---|
| Eligible substances | Follows the federal 503A framework |
The Board of Pharmacy regulates pharmacies under the South Carolina Pharmacy Practice Act (title 40, chapter 43). Section 40-43-83 requires a permit for in-state facilities and for each permittee outside South Carolina that ships, mails, or delivers prescription drugs into the state, and allows the Board to refuse a permit that is not in the public interest. Section 40-43-86 sets facility and practice requirements, including compounding; subsection (CC)(2) bars pharmacists from offering compounded medications to other pharmacies for resale. The Board's non-resident pharmacy permit application states that South Carolina has no separate sterile or non-sterile compounding permit, but any applicant that compounds must submit its compounding documentation even if it does not plan to ship compounds into the state: for non-sterile work, 6 hours of initial and 4 hours of annual compounding education for pharmacists and technicians, a diagram and photographs of the compounding area, and temperature, humidity, and cleaning logs; for sterile work, compounding training records, a diagram and photographs of the sterile area, a month of pressure differential, temperature, humidity, and cleaning logs, and the last certification of hoods and clean areas. The Board's permit page adds that under Regulation 99-43(G)(3)(b) the pharmacist-in-charge or permit holder must appear before the Non-Resident Application Review Committee in lieu of an in-person inspection. South Carolina has not adopted a separate state list of compoundable bulk substances, so eligibility follows the federal 503A test (approved drug component, USP or NF monograph, or FDA 503A bulks list). [1] [5] [6] [7] [8] [9] [10]
Can you get compounded GLP-1s in South Carolina?
Telehealth GLP-1 patients should confirm that the prescriber holds a South Carolina license and that any mail order pharmacy holds a South Carolina nonresident permit under section 40-43-83. [3] [6] [13]
Prices by channel: semaglutide cost, tirzepatide cost.
Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.
What is the legal access path in South Carolina?
Access options
Prescriber licensed in South Carolina, in person or by telehealth
Telehealth prescribing of non-controlled peptides is permitted in South Carolina. The state law we checked does not settle whether a prescription can be issued without a live visit, so expect one. State law says an online questionnaire alone is not enough.
Check the dispensing pharmacy against the board's license lookup before paying, including out-of-state mail-order pharmacies.
Branded GLP-1 through a retail or manufacturer pharmacy
FDA approved semaglutide and tirzepatide are available by prescription. Compounded GLP-1 limited; see the GLP-1 section for why.
CJC-1295 / Ipamorelin from Bodybuilding Peptides
SponsoredPartner lists from $220/month
Tesamorelin / Ipamorelin from Bodybuilding Peptides
SponsoredPartner lists from $274/month
Semax / Selank from Bodybuilding Peptides
SponsoredPartner lists from $274/month
We may earn a commission from these links.
Prices are the partner's own and are not verified by PeptideAgent. You answer health questions after checkout, and the partner's clinician decides whether to prescribe.
Unsponsored access paths are checked against public regulatory records. Sponsored offers are the partner's and are labeled. Products labeled research use only are never listed.
Find a provider in South Carolina
What you'll actually find in South Carolina, and how to check
Licensed compounding pharmacies, clinics, and telehealth prescribers openly offer many unapproved peptides, and prescribers write prescriptions for them. [16] [17] [18]
No FDA oversight of the specific product: FDA does not check a compounded drug's safety, effectiveness, or quality before it is sold. [19]
What South Carolina has done
PeptideAgent has not found a board or legislative action on peptides in South Carolina.
Other states have acted:
- On August 19, 2026, Mississippi's medical, nursing, and pharmacy boards said no licensed provider may prescribe, recommend, supply, or administer a peptide that is not FDA approved, and that a consent form does not remove the provider's liability. [21] Mississippi law
- Louisiana acted by statute: Act 374, in effect August 1, 2026, bars its licensing boards from prohibiting peptides only when they come from a pharmacy or outsourcing facility that complies with federal compounding law. It does not make any peptide eligible to compound. [22] [23] Louisiana law
Checking the prescriber
Telehealth prescribing of non-controlled peptides is permitted in South Carolina. The state law we checked does not settle whether a prescription can be issued without a live visit, so expect one. State law says an online questionnaire alone is not enough. [3] [4] The telehealth rule in full.
Checking the pharmacy
Look the pharmacy up yourself before you pay, including an out-of-state mail-order pharmacy. The pharmacy regulator is the South Carolina Board of Pharmacy (South Carolina Department of Labor, Licensing and Regulation); its license search: FDA BeSafeRx: state board of pharmacy license lookups. [20]
If you're going ahead anyway
These steps lower some risks. They do not make a compounded product safe, and FDA has not reviewed it. [19]
They do not change a peptide's legal status either. That depends on the peptide: for a withdrawn nomination such as BPC-157 or TB-500, a 503A pharmacy has no federal basis to compound it from bulk, with or without a prescription, while a few Category 1 substances, such as NAD+ and glutathione, are compounded under FDA's interim policy, with conditions. Each peptide page gives its status. [11] [24] [25]
Check the pharmacy's license. Look the pharmacy up yourself on your state board of pharmacy's license search; FDA's BeSafeRx page links every state's. If the pharmacy is not listed, or is not licensed in your state, do not use it. [20] [26] [27]
What a legitimate prescription and consult look like. Federal law lets a pharmacy compound only for an identified patient on a valid prescription. A legitimate prescriber is licensed in the state where you are, evaluates you, and tells you the drug is compounded and not FDA approved, and a telehealth company should say which pharmacy compounds it. A seller that needs no prescription, or a pharmacy with no pharmacist to answer questions, is a warning sign. [18] [27] [28]
Why this is safer than a research-use-only product. A state-licensed pharmacy answers to its state board and has a pharmacist you can reach. A product labeled "research use only" or "not for human consumption" has neither, and FDA treats such products sold for people as unapproved drugs. In a 2024 study of semaglutide sold online without a prescription, half of six orders never arrived, and every vial that did was rated probably substandard or falsified, held more drug than its label said, and contained endotoxin. Black-market growth peptides have also contained modified molecules the label did not name. Safer is not safe: compounded drugs can also be contaminated or have too much or too little active ingredient. [19] [29] [30] [31] [32] [33]
Check for:
- A 503A pharmacy licensed in your state (your state board of pharmacy publishes license lookups). [19]
- A real evaluation by a licensed prescriber, not just an online form.
- A certificate of analysis for the specific batch.
Questions to ask
- Pharmacy: What is your license number, and are you licensed in my state? Then check it yourself on the state board's site. [20]
- Telehealth company: Which pharmacy compounds and ships this, and is it a 503A pharmacy or a 503B outsourcing facility? [18]
- Pharmacy: Is this made for me on a prescription written in my name? [28]
- Prescriber: Are you licensed where I am, and will you evaluate me yourself rather than rely on a questionnaire? [18] [27]
- Anyone offering it: Does anyone call it "FDA approved", "generic", or from an "FDA-approved pharmacy"? None of these is true of a compounded drug, so the claim is a red flag. [18]
What is offered for a specific peptide, and what FDA found, is on each peptide page.
Is it legal to buy research peptides in South Carolina?
The South Carolina Pharmacy Practice Act limits dispensing of prescription drugs to permitted pharmacies and licensed practitioners, so an online seller shipping "research use only" injectable peptides to South Carolina consumers is not operating as a pharmacy under chapter 43. The South Carolina Board of Medical Examiners has also issued a notice that a physician may not compound, administer, prescribe, or dispense research-grade or FDA-ineligible peptides, may not delegate those acts to APRNs or PAs, and cannot rely on a patient consent form. The notice states that facilities inside or outside South Carolina may not sell or dispense drugs without a Board of Pharmacy license (S.C. Code 40-43-83 and 40-43-89), that physicians, APRNs, PAs, and pharmacists must buy all prescription products and compounding ingredients from Board of Pharmacy permitted entities, and that buying from an unpermitted source can be misconduct under S.C. Code 40-47-110(B). [5] [14] [15]
Peptide-specific notes for South Carolina
No peptide-specific rule identified for this jurisdiction. The general compounding and telehealth rules above apply, and the federal record covers semaglutide, tirzepatide, and BPC-157.
Frequently asked questions
Can I get a GLP-1 prescription in South Carolina through telemedicine?
Yes, from a physician licensed in South Carolina who meets section 40-47-37. A physician who practices solely by telemedicine must provide an appropriate evaluation, which need not be in person if the physician can accurately diagnose and treat you under the standard of care, and must obtain your medical history in an interview the prescriber conducts at each encounter. Section 40-47-113(C) says prescribing based solely on answers to a set of questions is unprofessional, and state law does not settle whether the interview must be live. Semaglutide and tirzepatide are not controlled substances, so the Schedule II and III telemedicine limits do not apply. [3] [4]
Will a South Carolina telehealth doctor prescribe from an online form alone?
No. Section 40-47-113(C) says prescribing drugs to someone the licensee has never personally examined based solely on answers to a set of questions is unprofessional. Section 40-47-37 also requires a licensee who practices solely by telemedicine to obtain the information needed for an accurate diagnosis in a medical history interview the prescriber conducts at each encounter. The statute does not say whether that interview must take place in real time, so state law does not settle whether a visit without a live exchange is enough. [3] [4]
Does an out-of-state pharmacy need a South Carolina permit to mail me compounded peptides?
Yes. Section 40-43-83 requires out-of-state pharmacies that ship or deliver prescription drugs to South Carolina residents to hold a Board of Pharmacy permit, and the Board can refuse a permit it finds is not in the public interest. The Board's non-resident application requires any pharmacy that compounds to document compounding training, submit a diagram and photographs of its compounding areas, and provide environmental and cleaning logs, and its pharmacist-in-charge or permit holder must appear before the Board's Non-Resident Application Review Committee. [1] [6] [8] [9]
Can a South Carolina pharmacy compound peptides that are not on the FDA bulks list?
Generally no. South Carolina has no state bulks list of its own, so the federal 503A test applies: the substance must be a component of an approved drug, have a USP or NF monograph, or be on the FDA 503A bulks list. Peptides in FDA Category 2 cannot be compounded. [7] [10] [11]
Sources
Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, federal FDA guidance, and the FDA warning letters and studies behind what is offered.
- [1]South Carolina Board of Pharmacy (Department of Labor, Licensing and Regulation)
- [2]South Carolina Board of Medical Examiners
- [3]South Carolina Code section 40-47-37, Practice of telemedicine, requirements (title 40, chapter 47)
- [4]South Carolina Code section 40-47-113, Establishment of physician-patient relationship as prerequisite to prescribing drugs (title 40, chapter 47)
- [5]South Carolina Code title 40, chapter 43, South Carolina Pharmacy Practice Act
- [6]South Carolina Code section 40-43-83, In-state facilities and out-of-state mail order pharmacy service permits
- [7]South Carolina Code section 40-43-86, Facility requirements for pharmacies, including compounding
- [8]South Carolina Board of Pharmacy: Non-Resident Pharmacy Permit Application, including non-sterile and sterile compounding requirements (revised February 2019)
- [9]South Carolina Board of Pharmacy: facility permit types and non-resident application review
- [10]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
Cite this page
Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.
- APA style
PeptideAgent. (2026, October 4). Are peptides legal in South Carolina?. https://peptideagent.ai/legal/south-carolina- HTML link
<a href="https://peptideagent.ai/legal/south-carolina">Are peptides legal in South Carolina?</a>, PeptideAgent, updated October 4, 2026.